Baxter International Price Target Lowered to $77.00 at BMO Capital Markets (BAX)
Analysts at BMO Capital Markets decreased their price target on shares of Baxter International (NYSE:BAX) from $82.00 to $77.00 in a research report issued to clients and investors on Monday, Analyst Ratings Network.com reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ price target would suggest a potential upside of 17.58% from the stock’s previous close.
Baxter International (NYSE:BAX) traded up 0.08% during mid-day trading on Monday, hitting $65.49. The stock had a trading volume of 2,970,314 shares. Baxter International has a 52-week low of $59.61 and a 52-week high of $74.60. The stock’s 50-day moving average is $71.65 and its 200-day moving average is $70.87. The company has a market cap of $35.547 billion and a price-to-earnings ratio of 16.57.
Baxter International (NYSE:BAX) last released its earnings data on Thursday, October 17th. The company reported $1.19 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.19. The company had revenue of $3.80 billion for the quarter, compared to the consensus estimate of $3.82 billion. During the same quarter in the previous year, the company posted $1.14 earnings per share. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. Analysts expect that Baxter International will post $4.66 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Baxter International in a research note to investors on Friday, October 18th. They now have a $71.00 price target on the stock. Separately, analysts at Morgan Stanley downgraded shares of Baxter International from an “overweight” rating to an “equal weight” rating in a research note to investors on Friday, October 18th. Finally, analysts at Raymond James downgraded shares of Baxter International from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, October 18th. They now have a $80.00 price target on the stock. Nine research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Baxter International has a consensus rating of “Buy” and a consensus target price of $75.88.
Baxter International Inc (NYSE:BAX) is a global, diversified healthcare company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.